Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000394208

Medchemexpress LLC D-3263 hydrochloride | 1008763-54-9 | 98.12% | 409.95 | 100 MG
SDP

Catalog No. 5000394208
Encompass_Preferred

D-3263 hydrochloride is an enteric-coated, orally bioavailable transient receptor potential melastatin member 8 (TRPM8) agonist. It binds to and activates TRPM8, which may lead to an increase in calcium and sodium entry, disruption of calcium and sodium homeostasis, and induction of cell death in TRPM8-expressing tumor cells. D-3263 hydrochloride may also decrease dihydrotestosterone (DHT) levels, potentially contributing to its inhibitory effects on prostate cancer and benign prostatic hyperplasia (BPH).

  • Binds to and activates TRPM8.
  • Increases calcium and sodium entry into cells.
  • Disrupts calcium and sodium homeostasis.
  • Induces cell death in TRPM8-expressing tumor cells.
  • Decreases dihydrotestosterone (DHT) levels.
  • Inhibits prostate cancer and benign prostatic hyperplasia (BPH).

Catalog No. 50-003-94208 Supplier Medchemexpress LLC Supplier No. HY16162A100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

D-3263 hydrochloride is an enteric-coated, orally bioavailable transient receptor potential melastatin member 8 (TRPM8) agonist. It binds to and activates TRPM8, which may lead to an increase in calcium and sodium entry, disruption of calcium and sodium homeostasis, and induction of cell death in TRPM8-expressing tumor cells. D-3263 hydrochloride may also decrease dihydrotestosterone (DHT) levels, potentially contributing to its inhibitory effects on prostate cancer and benign prostatic hyperplasia (BPH).

  • Binds to and activates TRPM8.
  • Increases calcium and sodium entry into cells.
  • Disrupts calcium and sodium homeostasis.
  • Induces cell death in TRPM8-expressing tumor cells.
  • Decreases dihydrotestosterone (DHT) levels.
  • Inhibits prostate cancer and benign prostatic hyperplasia (BPH).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.